基因總覽
SCN1A(sodium voltage-gated channel alpha subunit 1)是蛋白質編碼基因,其產物為 Nav1.1 電壓閘控鈉離子通道的成孔 α 次單元,屬於鈉離子通道家族的 Nav1.1/SCN1A 次家族。這是一種多次穿越細胞膜的蛋白質;其通道可依膜兩側電位差在關閉與開啟構形間切換,開啟時讓 Na(+) 通過。Nav1.1 的 α 次單元本身具有功能,並可由一種或多種 β 次單元調節。
基因異名與舊稱
異名取自 HGNC,可能包含歷史名稱;蛋白質名稱以 UniProt 註解為準。
染色體位置與基因結構
查看實際轉錄本與 exon 註解
| Transcript | Genomic coordinates | Exons |
|---|---|---|
| ENST00000674923 ★ | 165,985,813–166,128,020 | 29 |
| ENST00000641575 | 165,984,641–166,149,214 | 28 |
| ENST00000641603 | 165,984,641–166,149,214 | 26 |
| ENST00000303395 | 165,984,641–166,128,020 | 28 |
| ENST00000640036 | 165,984,641–166,073,670 | 26 |
| ENST00000637988 | 165,984,641–166,128,023 | 29 |
| ENST00000635750 | 165,984,641–166,149,214 | 27 |
| ENST00000713692 | 165,984,641–166,128,023 | 29 |
| ENST00000409050 | 165,984,641–166,149,214 | 28 |
| ENST00001144292 | 165,984,641–166,128,020 | 29 |
| ENST00000635776 | 165,989,160–166,128,023 | 26 |
| ENST00000637285 | 166,073,611–166,127,054 | 2 |
顯示 12/12 個蛋白質編碼轉錄本;canonical 優先。
帶型與著絲點依 Ensembl 座標繪製;核染色體長度以 GRCh38 第 1 號染色體為共同尺度。黃色標記表示本基因位置,細小區間加粗以利辨識;實際基因長度與 exon 見下方資料。
分子功能與生物學過程
Nav1.1 直接介導可興奮細胞膜上動作電位的去極化階段。通道會依膜兩側的電位差在關閉與開啟構形間轉換;開啟時,Na(+) 沿電化學梯度選擇性通過孔道,離子流入使細胞膜去極化,進而啟動電訊號在細胞與組織中的傳播。來源所列的活性方向為 Na(+)(in) = Na(+)(out)。
在神經元中,Nav1.1 有助調節細胞興奮性,使神經元適切回應突觸輸入,並維持腦神經迴路中興奮與抑制的平衡;此項神經迴路功能為相似性推定。Nav1.1 也被推定參與體感神經元的興奮性及動作電位傳播,因而有助於機械性疼痛的感知。這些描述屬於 By similarity 的功能推定,並非來源所述的直接實驗證明。
SCN1A 編碼的 α 次單元亦可在 β 次單元調節下運作。SCN1B 會影響 Nav1.1 在細胞膜的表現,以及通道失活對電壓的依賴性;SCN3B 和 SCN4B 則會降低 Nav1.1 的電導。來源亦指出,FGF13 會調節 Nav1.1 的穩態失活,而 TMEM233 可能調節其閘控性質。這些調節關係顯示通道活性不只取決於電壓變化,也會受到相關蛋白質影響。
Promoter 與基因調控
>SCN1A ENST00000674923 GRCh38 chr2:166127920-166129020 strand=-1 5′→3′ 相對 TSS:-1000 到 +100 bp;1101 bp 依轉錄本 TSS 擷取的基因組序列;TSS = 0,兩端包含,未驗證為 promoter AAAAGAAAAATAATGAGGATGAAATATTTACTTCCAATGACTAATCTACACATAATCGTGATTTTATGTA TGACTGAATGTTTAAGGCTGATTCCATTTTAGAATACAATATATAACATAAAAAGCTCTACTCTCAGTTC CAAGAGTTATAATTAGTTTGGCATGGATTTTTATTGTCTTAGAAAAAACTGATATTCATGGTTTTTATAA TTCTATCTTTGGGTAATAGGCAATTGGACTCTCTTTCTATATATATTTGCTTATTAAAATGTGTTATTAT AATTAAGCTTTAGGCTGTGTCCACAAGATGGGAAAACATTGGAGTAAAATATAGTAAAACCATAGAAATT GAGAGTGGGTTGAAAGTCTTGTTTAATCTGTAATTACAGATGAAGATAGTAAGAATGTAAATGTCCATAG AAGACTTCAGTGGCTTTGTTAAAGGCATGTGTTCATCAGTGTTGAAGTAAAACTCACATTTTGTGACTCT GAGCTGTTCACTATAATATGAAACCTAATCCTAAAACACAATATTAAAACAGAAAAATGTGAAGCCATAG ATCTGTAATAAAGGGCCACCTGATTGTTTCCTGGTGGAATAAAAAGACAGTTTTATTTATAAGATATATC ATTTTTATAGATAACAATGATTCATATTAGGAATAAAGTAACAGTTTCAAACTAAAATAATGCTAAAGTT TTTCAAGTACTACTTGAAAATAGCTATATTTACTTTCAAACCTTTTCCTCTTTGAGTCATTAGGTTCATG ATATTATATAGCAATAGGGAATGAAAGAGAAGCAAGGAGAAGCAATACTGGGAGATTACAGAGAAGAAAG GAAAAAAGGCTGAGAGAAAAGAGGTTGAGGAAGAAATCATAAATCTGGATTGTGAGAAAGTGTTTAATAT TTAGCCACTAGATGGCGATGTAATGTAAGGTGCTGTCTTGACTTTTTTTTTTTTTTTTTGAAACAAGCTA TTTGCTGATTTGTATTAGGTACCATAGAGTGAGGCGAGGATGAAGCCGAGAGGATACTGCAGAGGTCTCT GGTGCATGTGTGTATGTGTGCGTTTGTGTGTGTTTGTGTGTCTGTGTGTTC
EPDnew 實驗支持 promoter/TSS · 0 筆
封存資料的查詢區間內未找到名稱與股向相符的紀錄;不代表此基因沒有 promoter。
EPDnew human v006 · UCSC hg38,GRCh38/hg38,透過 UCSC 取得。TSS 具有 CAGE/RAMPAGE 等實驗資料支持;任意擷取的上下游區間仍需另行判讀調控功能,不能視為整段皆經功能驗證。
EPD 封存狀態 ↗ · UCSC 資料說明 ↗ · EPD team, SIB Swiss Institute of Bioinformatics; UCSC Genome Browser · CC BY 4.0
查看已取得的調控/motif 註解
ENSR2_94FXBX · enhancer · 166126045–166126475 · regulatory
ENSR2_86TTNS · enhancer · 166127800–166128004 · regulatory
ENSR2_86TTNX · promoter · 166128005–166128231 · regulatory
ENSR2_53G42LK · CTCF_binding_site · 166128090–166128111 · regulatory
· motif · 166127877–166127889 · motif
· motif · 166128092–166128108 · motif
蛋白質結構域與序列
參考蛋白質長度:2009 aa
Nav1.1 長 2009 個胺基酸,屬於 sodium channel(TC 1.A.1.10)家族。其膜內部分包含四個重複區,每區各有 S1 至 S6 六段螺旋跨膜區;膜外與細胞質區段穿插於其間。這些跨膜區共同構成多次穿膜的蛋白質架構。
蛋白質三維結構
細胞內定位
Nav1.1 定位於細胞膜,是多次穿膜蛋白。 來源未提供定位隨條件改變或不同異構型之間差異的資訊。
深綠色圓點:來源記載的蛋白質定位;數量不表示含量。
動物細胞結構示意;器官大小與數量不按比例。點選細胞構造可查看定位註解。
交互作用與訊號網絡
拖曳節點後放開可帶動位置變化;點選夥伴查看證據。位置與連線長度不代表結合強度,圖中未推定夥伴彼此之間的關係。
SCN1A 的 α 次單元本身具有功能,也可與 SCN1B、SCN2B、SCN3B 或 SCN4B 組成受調節的通道;SCN1B、SCN3B 為非共價結合,SCN2B、SCN4B 則以二硫鍵連結。SCN1B 影響細胞膜表現及失活的電壓依賴性,SCN3B 和 SCN4B 降低電導。FGF13 與 Nav1.1 互作並調節其穩態失活;Nav1.1 與 TMEM233 的互作則屬可能,並被認為可調節閘控性質。
疾病與遺傳關聯
影響 SCN1A 的變異與多種癲癇相關,包括熱性痙攣加重型全身性癲癇 2、Dravet syndrome、嬰兒期起病的難治性全身強直陣攣癲癇,以及發展性與癲癇性腦病 6B。相關表現可包括發熱誘發或其他類型的發作,部分病況伴隨發展遲緩或動作異常;嚴重度與臨床表現各有差異。SCN1A 變異也與家族性偏癱型偏頭痛 3及家族性熱性痙攣 3A相關。另有資料指出,SCN1A 突變可能涉及 Panayiotopoulos syndrome;此處的關聯屬可能性描述,不應解讀為已確立因果。
Contextual Functional Evidence Matrix
矩陣以「功能主張」為列,以細胞情境、干預條件、量測結果與證據來源為欄,方便比較同一功能在不同條件下的支持情形。只有含情境與實驗資訊的紀錄會列入矩陣;一般功能註解另列於下方。
功能註解總覽 · 11 筆
| 功能面向 | 功能敘述 | 證據類型 | 可查核來源 |
|---|---|---|---|
| 功能 | Nav1.1 是電壓閘控鈉離子通道的成孔次單元,直接介導可興奮細胞動作電位的去極化階段。通道依膜電位差開關,開啟時使 Na(+) 沿電化學梯度選擇性流入,促進細胞與組織的電訊號傳播。神經元興奮性調節、興奮與抑制平衡,以及體感神經元對機械性疼痛的感知均為相似性推定。 | 含實驗來源 | 證據與來源Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na(+) ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues. By regulating the excitability of neurons, ensures that they respond appropriately to synaptic inputs, maintaining the balance between excitation and inhibition in brain neural circuits (By similarity). Nav1.1 plays a role in controlling the excitability and action potential propagation from somatosensory neurons, thereby contributing to the sensory perception of mechanically-induced pain (By similarity) PMID 14672992 ↗ |
| 分子活性 | Na(+)(in) = Na(+)(out) | 含實驗來源 | |
| 交互作用 | SCN1A 的離子傳導 α 次單元本身具有功能,也可受 SCN1B、SCN2B、SCN3B 或 SCN4B 調節。SCN1B、SCN3B 與 SCN1A 非共價結合,SCN2B、SCN4B 以二硫鍵連結;SCN1B 影響膜表現及失活的電壓依賴性,SCN3B、SCN4B 降低電導。FGF13 調節穩態失活;與 TMEM233 的互作及其閘控調節作用則屬可能。 | 含實驗來源 | 證據與來源The Nav1.1 voltage-gated sodium channel consists of an ion-conducting alpha subunit SCN1A which is functional on its own regulated by one or more beta-1 (SCN1B), beta-2 (SCN2B), beta-3 (SCN3B) and beta-4 (SCN4B) subunits. SCN1B and SCN3B are non-covalently associated with SCN1A. SCN2B and SCN4B are disulfide-linked to SCN1A. SCN1B regulates both the expression at the plasma membrane and the voltage dependence of Nav1.1 inactivation. SCN3B and SCN4B reduce Nav1.1 conductance. Probably interacts with TMEM233; modulates the gating properties of NaV1.1 (Probable). Interacts with FGF13; regulates the steady-state inactivation of Nav.1.1 PMID 15525788 ↗ · PMID 17928445 ↗ · PMID 21566136 ↗ · PMID 33712547 ↗ · PMID 37117223 ↗ |
| 細胞定位 | SCN1A 蛋白定位於細胞膜,屬於多次穿膜蛋白。 | 含實驗來源 | |
| 疾病關聯 | 熱性痙攣加重型全身性癲癇 2 是罕見的常染色體顯性家族性疾病,具有不完全外顯率且家族內表現差異大。患者可能有超過 6 歲仍持續的熱性痙攣,或不同類型的非熱性發作;表現可包含發熱誘發的全身性發作及局部發作,嚴重程度不一。此病與影響 SCN1A 的變異相關。 | 含實驗來源 | 證據與來源Generalized epilepsy with febrile seizures plus 2 GEFSP2 A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity. The disease is caused by variants affecting the gene represented in this entry MIM: 604403 PMID 10742094 ↗ · PMID 11254444 ↗ · PMID 11254445 ↗ · PMID 11524484 ↗ · PMID 11756608 ↗ · PMID 12535936 ↗ · PMID 12576172 ↗ · PMID 12919402 ↗ · PMID 14672992 ↗ · PMID 15525788 ↗ · PMID 15694566 ↗ · PMID 15715999 ↗ · PMID 16525050 ↗ · PMID 17347258 ↗ · PMID 17507202 ↗ · PMID 17561957 ↗ · PMID 17927801 ↗ · PMID 17928445 ↗ · PMID 18251839 ↗ · PMID 18413471 ↗ · PMID 18566737 ↗ · PMID 19339291 ↗ · PMID 19464195 ↗ · PMID 19522081 ↗ · PMID 20117752 ↗ · PMID 20550552 ↗ · PMID 20600615 ↗ · PMID 20729507 ↗ · PMID 21248271 ↗ · PMID 21864321 ↗ |
| 疾病關聯 | Dravet syndrome 是嚴重的癲癇性腦病,發作通常在出生第一年開始,起初為發熱誘發的全身性強直、陣攣或強直陣攣發作,之後也可能出現失神、肌陣攣及單純或複雜局部發作。約第二年可見精神運動發展遲緩;部分患者表現較輕,未必符合核心診斷標準。該病與影響 SCN1A 的變異相關,並被列為熱性痙攣加重型全身性癲癇譜系中最嚴重的表型。 | 含實驗來源 | 證據與來源Dravet syndrome DRVT A severe form of epileptic encephalopathy characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development delay is observed around the second year of life. Some patients manifest a borderline disease phenotype and do not necessarily fulfill all diagnostic criteria for core DRVT. DRVT is considered to be the most severe phenotype within the spectrum of generalized epilepsies with febrile seizures-plus. The disease is caused by variants affecting the gene represented in this entry MIM: 607208 PMID 11359211 ↗ · PMID 12083760 ↗ · PMID 12566275 ↗ · PMID 12754708 ↗ · PMID 12821740 ↗ · PMID 14504318 ↗ · PMID 14672992 ↗ · PMID 14738421 ↗ · PMID 15087100 ↗ · PMID 15944908 ↗ · PMID 16122630 ↗ · PMID 16458823 ↗ · PMID 16713920 ↗ · PMID 17054684 ↗ · PMID 17054685 ↗ · PMID 17129991 ↗ · PMID 17347258 ↗ · PMID 17561957 ↗ · PMID 18413471 ↗ · PMID 18639757 ↗ · PMID 18930999 ↗ · PMID 19522081 ↗ · PMID 19563458 ↗ · PMID 19589774 ↗ · PMID 19783390 ↗ · PMID 20110217 ↗ · PMID 20431604 ↗ · PMID 20452746 ↗ · PMID 20522430 ↗ · PMID 20729507 ↗ |
| 疾病關聯 | 嬰兒期起病的難治性全身強直陣攣癲癇通常以發熱誘發的全身強直陣攣發作為特徵,發作後可能出現心智衰退、共濟失調或肌張力低下。此病與影響 SCN1A 的變異相關,臨床上類似 SMEI,但不包含肌陣攣發作。 | 含實驗來源 | 證據與來源Intractable childhood epilepsy with generalized tonic-clonic seizures ICEGTC A disorder characterized by generalized tonic-clonic seizures beginning usually in infancy and induced by fever. Seizures are associated with subsequent mental decline, as well as ataxia or hypotonia. ICEGTC is similar to SMEI, except for the absence of myoclonic seizures. The disease is caused by variants affecting the gene represented in this entry MIM: 607208 PMID 12566275 ↗ · PMID 16210358 ↗ · PMID 17507202 ↗ · PMID 23195492 ↗ · PMID 23708187 ↗ |
| 疾病關聯 | 家族性偏癱型偏頭痛 3 是偏頭痛亞型,部分家族伴有短暫失明。典型偏頭痛可呈週期性、通常位於顳側且單側的頭痛,可能伴隨易怒、噁心、嘔吐與畏光;有先兆型可在頭痛前或發作時出現可逆神經症狀,如視覺或感覺異常、眩暈、麻木及注意或語言困難。此病與影響 SCN1A 的變異相關。 | 含實驗來源 | 證據與來源Migraine, familial hemiplegic, 3 FHM3 A subtype of migraine associated with transient blindness in some families. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. The two major subtypes are common migraine (migraine without aura) and classic migraine (migraine with aura). Classic migraine is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking. The disease is caused by variants affecting the gene represented in this entry MIM: 609634 PMID 16054936 ↗ · PMID 17397047 ↗ · PMID 18021921 ↗ · PMID 19332696 ↗ · PMID 33712547 ↗ |
| 疾病關聯 | 家族性熱性痙攣 3A 指兒童發熱時出現、且沒有顱內感染或明確病理與創傷原因的發作。資料指出此狀況常見,影響 3 個月至 5 歲兒童的 2–5%;多數為單純型,通常是單次全身起始且少於 30 分鐘。複雜型可為局部起始、持續超過 30 分鐘或 24 小時內多次發作;單純型後續癲癇風險低,複雜型則與中度增加的癲癇發生率相關。此病與影響 SCN1A 的變異相關。 | 含實驗來源 | 證據與來源Febrile seizures, familial, 3A FEB3A Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. The disease is caused by variants affecting the gene represented in this entry MIM: 604403 PMID 16326807 ↗ · PMID 19522081 ↗ |
| 疾病關聯 | 發展性與癲癇性腦病 6B 屬癲癇性腦病,這類疾病包含嚴重早發癲癇、難治性發作、神經發展受損及預後不佳等表現。患者在發作前可正常發展,發作後出現認知與動作遲緩。此病為常染色體顯性,通常在嬰兒早期起病,並可有嚴重智能發展受損與過度動作障礙;病因與影響 SCN1A 的變異相關。 | 含實驗來源 | 證據與來源Developmental and epileptic encephalopathy 6B DEE6B A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE6B is an autosomal dominant condition characterized by onset of seizures in early infancy, profoundly impaired intellectual development, and a hyperkinetic movement disorder. The disease is caused by variants affecting the gene represented in this entry MIM: 619317 PMID 17347258 ↗ · PMID 24776920 ↗ · PMID 28794249 ↗ |
| 疾病關聯 | SCN1A 突變可能涉及 Panayiotopoulos syndrome,這是一種發生於兒童早期與中期、與年齡相關的良性局部發作疾病。發作常持續較久,以自主神經症狀為主;腦電圖可見位置變動或多個病灶,常以枕葉為主。自主神經發作可造成自主功能異常,其中嘔吐最為突出;心肺停止則屬罕見情形。 | 含實驗來源 | 證據與來源SCN1A mutations may be involved in Panayiotopoulos syndrome, a benign age-related focal seizure disorder occurring in early and mid-childhood. It is characterized by seizures, often prolonged, with predominantly autonomic symptoms, and by an electroencephalogram that shows shifting and/or multiple foci, often with occipital predominance. Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom. Cardiorespiratory arrest is exceptional PMID 17679682 ↗ · PMID 19339291 ↗ · PMID 19522081 ↗ |
核酸與蛋白質序列
ACCATAGAGTGAGGCGAGGATGAAGCCGAGAGGATACTGC40AGAGGTCTCTGGTGCATGTGTGTATGTGTGCGTTTGTGTG80TGTTTGTGTGTCTGTGTGTTCTGCCCCAGTGAGACTGCAG120CCCTTGTAAATACTTTGACACCTTTTGCAAGAAGGAATCT160GAACAATTGCAACTGAAGGCACATTGTTATCATCTCGTCT200TTGGGTGATGCTGTTCCTCACTGCAGATGGATAATTTTCC240TTTTAATCAGAACAGCATAAGAATTATTTCTGAGTGGAGG280TGAGGCTTGTCCAAATGTCTTTGCTATCATGGATTTCCTG320ACTCCTACCTGTTTGAGGTTTGGGCAATTATGAATAAGGC360TGCTGTATACATCCGTGTGCAGGATTTTGTGTGGACATAA400GTTTTCAACTCCTTTGGTTAAATCCTAAGGAATTTCATAT440GCAGAATAAATGGTAATTAAAATGTGCAGGATGACAAGAT480GGAGCAAACAGTGCTTGTACCACCAGGACCTGACAGCTTC520AACTTCTTCACCAGAGAATCTCTTGCGGCTATTGAAAGAC560GCATTGCAGAAGAAAAGGCAAAGAATCCCAAACCAGACAA600AAAAGATGACGACGAAAATGGCCCAAAGCCAAATAGTGAC640TTGGAAGCTGGAAAGAACCTTCCATTTATTTATGGAGACA680TTCCTCCAGAGATGGTGTCAGAGCCCCTGGAGGACCTGGA720CCCCTACTATATCAATAAGAAAACTTTTATAGTATTGAAT760AAAGGGAAGGCCATCTTCCGGTTCAGTGCCACCTCTGCCC800TGTACATTTTAACTCCCTTCAATCCTCTTAGGAAAATAGC840TATTAAGATTTTGGTACATTCATTATTCAGCATGCTAATT880ATGTGCACTATTTTGACAAACTGTGTGTTTATGACAATGA920GTAACCCTCCTGATTGGACAAAGAATGTAGAATACACCTT960cDNA 使用 DNA 字母 T;mRNA 模式改以 U 顯示。轉錄本保留已註解的非編碼區,未另外加入 poly(A) 尾;非編碼 RNA 的參考轉錄本也可能仍需後續加工。數字為所選序列的 1-based 位置。長序列以黃色捲軸瀏覽,可複製或下載完整轉錄本與蛋白質;基因組 DNA 隨捲動取得所需範圍。